EMD-14143
SARS-CoV-2 S Omicron Spike B.1.1.529 - RBD down - 1-P2G3 Fab (Local)
EMD-14143
Single-particle3.84 Å
Deposition: 14/01/2022Map released: 03/08/2022
Last modified: 23/10/2024
Sample Organism:
Severe acute respiratory syndrome coronavirus 2,
Homo sapiens
Sample: Spike Omicron trimer with Fabs
Fitted models: 7qtk
Deposition Authors: Ni D, Lau K
Sample: Spike Omicron trimer with Fabs
Fitted models: 7qtk
Deposition Authors: Ni D, Lau K
Patient-derived monoclonal antibody neutralizes SARS-CoV-2 Omicron variants and confers full protection in monkeys.
Fenwick C ,
Turelli P ,
Ni D,
Perez L ,
Lau K ,
Herate C ,
Marlin R ,
Lana E,
Pellaton C ,
Raclot C ,
Esteves-Leuenberger L,
Campos J,
Farina A,
Fiscalini F,
Dereuddre-Bosquet N ,
Relouzat F,
Abdelnabi R ,
Foo CS,
Neyts J ,
Leyssen P ,
Levy Y ,
Pojer F,
Stahlberg H ,
LeGrand R,
Trono D ,
Pantaleo G
(2022) Nat Microbiol , 7 , 1376 - 1389
,
Turelli P ,
Ni D,
Perez L ,
Lau K ,
Herate C ,
Marlin R ,
Lana E,
Pellaton C ,
Raclot C ,
Esteves-Leuenberger L,
Campos J,
Farina A,
Fiscalini F,
Dereuddre-Bosquet N ,
Relouzat F,
Abdelnabi R ,
Foo CS,
Neyts J ,
Leyssen P ,
Levy Y ,
Pojer F,
Stahlberg H ,
LeGrand R,
Trono D ,
Pantaleo G
(2022) Nat Microbiol , 7 , 1376 - 1389
Grant Support:
- Swiss National Science Foundation: (Switzerland)